Trial Profile
Efficiency of 5-aminolevulinic acid for amnestic mild cognitive impairment and early Alzheimer disease. Confirmatory randomized controlled trial
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 23 Nov 2016
Price :
$35
*
At a glance
- Drugs Aminolevulinic acid (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- 23 Nov 2016 New trial record